Overview
Investment Type
Venture Capital
Mentions in press and media 9
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Sep 27, 2011 | Unlimited Abilities: A View from the MedtechVision Conference | Share Share on Facebook Share on Twitter LinkedIn Email Reprints We are limited, not by our abilities, but by our vision. —Ralph Waldo Emerson In a world thick with healthcare conferences, MedtechVision, held September 15-16 at the Rosewood... |
| Aug 17, 2011 | Entellus Medical raises $35 million in series E fundraising | The money will be mainly used to increase commercialization of the company’s two products — FinESS that was approved in April 2008 and XprESS that was approved in February 2010, Griffin said. He noted that the capital will also help to furt... |
| Jun 30, 2011 | AEGEA Medical Closes $13.3M Venture Capital Financing | AEGEA Medical Inc., a Redwood City, Ca.-based developer of a novel, minimally invasive treatment for abnormal uterine bleeding, has completed a $13.3m venture capital financing. The round was led by Covidien Ventures, with participation fro... |
| Apr 10, 2011 | Corporate Venture Funds: What’s the Deal? | Covidien Ventures Covidien Ventures was formed in 2008 with the mission to “…invest in areas of strategic importance to the Company with the goal of providing early exposure to innovative technologies and enhancing market intelligence in he... |
| Aug 19, 2008 | Covidien Launches Venture Arm | Share Share on Facebook Share on Twitter LinkedIn Email Reprints Updated: Medical products giant Covidien (NYSE:COV) says it wants to play the venture capital game, announcing this morning that it has launched a corporate VC group to make s... |
| Entellus Medical raises $35 million in series E fundraising | Maple Grove, Minnesota-based Entellus Medical, which has developed minimally invasive treatments for chronic sinusitis, announced Wednesday that it has raised $35 million in its fifth round of financing. The round was led by new investor Co... | |
| Corporate Venture Funds: What’s the Deal? | For many big medical device companies, awash in cash and hungry for innovation, the decision to form a venture arm seems a natural one. No need to hassle with raising a fund or deal with demanding LPs; just hang out a shingle, set aside a r... | |
| GSK launches $50M fund to invest in pioneering bioelectronics technology | Updated About one year ago GlaxoSmithKline (NYSE: GSK) set up a division to study the electrical impulses along the peripheral nervous system and develop technologies to read, change, or manipulate these impulses to treat acute and chronic ... |
Reviews 0
FAQ about Medtronic Ventures
What has the press written about Medtronic Ventures?
Parsers VC has collected 9 articles mentioning Medtronic Ventures, among them “Unlimited Abilities: A View from the MedtechVision Conference” (Sep 27, 2011) and “Entellus Medical raises $35 million in series E fundraising” (Aug 17, 2011).
Is Medtronic Ventures still active?
Yes, Medtronic Ventures is active; its latest activity on Parsers VC dates from Aug 8, 2013.